Beeologics Inc.

Miami, FL, United States

Beeologics Inc.

Miami, FL, United States

Time filter

Source Type

Patent
Beeologics Inc. | Date: 2014-12-09

Compositions and methods for providing viral control in Varroa mites and bees using RNA interference technology, and more particularly, prevention and treatment of viral infections in Varroa mites and bees by providing trigger polynucleotides targeting viral sequences is disclosed.


Patent
Monsanto Corporation, Beeologics Inc. and The United States Of America | Date: 2016-12-14

This application provides and discloses anti-parasitic, anti-pest or insecticidal nucleic acid molecules and their calmodulin target genes for the control of arthropod parasites and pests. This application further provides methods and compositions for the control and treatment of parasites and pests in Apis mellifera (honey bee) hives.


Patent
Beeologics Inc. and Hebrew University of Jerusalem | Date: 2012-04-13

An isolated nucleic acid agent is disclosed comprising a nucleic acid sequence which downregulates expression of a gene product of a Varroa destructor mite. Compositions comprising same and uses thereof are also disclosed.


Patent
Hebrew University of Jerusalem and Beeologics Inc. | Date: 2015-01-27

An isolated nucleic acid agent is disclosed comprising a nucleic acid sequence which downregulates expression of a gene product of a Varroa destructor mite. Compositions comprising same and uses thereof are also disclosed.


Patent
Monsanto Corporation, Beeologics Inc. and The United States Of America | Date: 2014-11-04

This application provides and discloses anti-parasitic, anti-pest or insecticidal nucleic acid molecules and their calmodulin target genes for the control of arthropod parasites and pests. This application further provides methods and compositions for the control and treatment of parasites and pests in Apis mellifera (honey bee) hives.


Patent
Beeologics Inc. | Date: 2014-03-05

The present invention relates to a method for increasing the tolerance of a honeybee to a disease caused by a bee pathogen, comprising feeding the bee an effective amount of a bee-ingestible composition comprising an isolated double stranded ribonucleic acid (dsRNA) comprising an RNA sequence complementary to a nucleic acid comprising a nucleotide sequence that is highly homologous to a nucleotide sequence of at least one bee pathogen, thereby increasing the tolerance of the honeybee to the disease.


Patent
Beeologics Inc. | Date: 2014-09-01

Compositions and methods for reducing susceptibility and enhancing tolerance to Nosema disease (Nosemosis) using RNA interference technology, and more particularly, prevention and treatment of Nosema infections in honeybees by feeding of Nosema-specific dsRNA.


The present invention relates to a bee-ingestible composition comprising an isolated double stranded ribonucleic acid (dsRNA) comprising an RNA sequence complementary to a nucleic acid comprising a nucleotide sequence that is highly homologous to a nucleotide sequence of two or more bee viruses.


Compositions and methods for reducing susceptibility to infectious disease in bees using RNA interference technology, and more particularly, prevention and treatment of viral infections in honeybees such as Israel acute paralysis virus (IAPV) by feeding of pathogen-specific dsRNA. Further, multiple-pathogen specific dsRNA is disclosed.


The present invention relates to a bee-ingestible composition comprising an isolated double stranded ribonucleic acid (dsRNA) comprising an RNA sequence complementary to the nucleotide sequence set forth in SEQ ID NO: 33 and bee feed.

Loading Beeologics Inc. collaborators
Loading Beeologics Inc. collaborators